Current perspectives on vitamin D, immune system, and chronic diseases

Nutrition

Volumn 27, Issue 4, 2011, Pages 399-404

  Borges, Maria C ^a   Martini, Lígia A ^a   Rogero, Marcelo M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardiovascular disease; Diabetes; Immune diseases; Inflammation; Vitamin D

Indexed keywords

CALCITRIOL; CALCIUM; COLECALCIFEROL; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

ANTIBODY PRODUCTION; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; CYTOKINE PRODUCTION; DRUG EFFICACY; GENE EXPRESSION; GLUCOSE HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; TH1 CELL; TH2 CELL; VITAMIN INTAKE; VITAMIN METABOLISM;

ANIMALS; AUTOIMMUNE DISEASES; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; RECEPTORS, CALCITRIOL; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79952447378     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2010.07.022     Document Type: Review

References (83)

1. Bouillon R., Carmeliet G., Verlinden L., van Etten E., Verstuyf A., Luderer H.F., et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocrine Rev 2008, 29:726-776.
2. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
3. van Etten E., Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005, 97:93-101.
4. Samuel S., Sitrin M.D. Vitamin D's role in cell proliferation and differentiation. Nutr Rev 2008, 66:S116-S124.
5. Prentice A., Goldberg G.R., Schoenmakers I. Vitamin D across the lifecycle: physiology and biomarkers. Am J Clin Nutr 2008, 88:500S-506S.
6. Sigmundsdottir H., Pan J., Debes G.F., Alt C., Habtezion A., Soler D., et al. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol 2007, 8:285-293.
7. Fritsche J., Mondal K., Ehrnsperger A., Andreesen R., Kreutz M. Regulation of 25-hydroxyvitamin D3-1α-hydroxylase and production of 1α, 25-dihydroxyvitamin D3 by human dendritic cells. Blood 2003, 102:3314-3316.
8. Rosenbaum J.T., Pasadhika S., Crouser E.D., Choi D., Harrington C.A., Lewis J.A., et al. Hypothesis: sarcoidosis is a STAT1-mediated disease. Clin Immunol 2009, 132:174-183.
9. Dusso A.S., Kamimura S., Gallieni M., Zhong M., Negrea L., Shapiro S., et al. Gamma-interferon-induced resistance to 1,25-(OH)2D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses. J Clin Endocrinol Metab 1997, 82:2222-2232.
10. Bowen H., Kelly A., Lee T., Lavender P. Control of cytokine gene transcription in Th1 and Th2 cells. Clin Exp Allergy 2008, 38:1422-1431.
11. Alroy I., Towers T.L., Freedman L.P. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 1995, 15:5789-5799.
12. Cippitelli M., Santoni A. Vitamin D3: a transcriptional modulator of the interferon-gamma gene. Eur J Immunol 1998, 28:3017-3030.
13. Zhu J., Yamane H., Cote-Sierra J., Guo L., Paul W.E. GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res 2006, 16:3-10.
14. Cippitelli M., Fionda C., Di Bona D., Di Rosa F., Lupo A., Piccoli M., et al. Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes. J Immunol 2002, 168:1154-1166.
15. 3 exerts opposing effects to IL-4 on MHC class-II antigen expression, accessory activity, and phagocytosis of human monocytes. Scand J Immunol 1993, 38:535-540.
16. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
17. Murphy C., Newsholme P. Macrophage-mediated lysis of a beta-cell line, tumour necrosis factor-alpha release from bacillus Calmette-Guérin (BCG)-activated murine macrophages and interleukin-8 release from human monocytes are dependent on extracellular glutamine concentration and glutamine metabolism. Clin Sci 1999, 96:89-97.
18. Ghosh S., Hayden M.S. New regulators of NF-kappaB in inflammation. Nat Rev Immunol 2008, 8:837-848.
19. Vallabhapurapu S., Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Ann Rev Immunol 2009, 27:693-733.
20. Osborn L., Kunkel S., Nabel G.J. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA 1989, 86:2336-2340.
21. Cooke C.L., Davidge S.T. Peroxynitrite increases iNOS through NF-kappaB and decreases prostacyclin synthase in endothelial cells. Am J Physiol Cell Physiol 2002, 282:C395-C402.
22. Sen R., Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism. Cell 1986, 47:921-928.
23. Perkins N.D. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 2007, 8:49-62.
24. Cohen-Lahav M., Shany S., Tobvin D., Chaimovitz C., Douvdevani A. Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels. Nephrol Dial Transplant 2006, 21:889-897.
25. Sadeghi K., Wessner B., Laggner U., Ploder M., Tamandl D., Friedl J., et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 2006, 36:361-370.
26. Karvonen M., Jäntti V., Muntoni S., Stabilini M., Stabilini L., Muntoni S., et al. Comparison of the seasonal pattern in the clinical onset of IDDM in Finland and Sardinia. Diabetes Care 1998, 21:1101-1109.
27. Ponsonby A.L., Pezic A., Ellis J., Morley R., Cameron F., Carlin J., et al. Variation in associations between allelic variants of the vitamin D receptor gene and onset of type 1 diabetes mellitus by ambient winter ultraviolet radiation levels: a meta-regression analysis. Am J Epidemiol 2008, 168:358-365.
28. Bach J.F. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 1994, 15:516-542.
29. Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. Diabetologia 1999, 42:51-54. The EURODIAB Substudy 2 Study Group.
30. Stene L.C., Joner G. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am J Clin Nutr 2003, 78:1128-1134. for the Norwegian Childhood Diabetes Study Group.
31. Hyppönen E., Läärä E., Reunanen A., Järvelin M.R., Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001, 358:1500-1503.
32. Mathieu C., Waer M., Laureys J., Rutgeerts O., Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia 1994, 37:552-558.
33. Mathieu C., Waer M., Casteels K., Laureys J., Bouillon R. Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060. Endocrinology 1995, 136:866-872.
34. Zella J.B., McCary L.C., DeLuca H.F. Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch Biochem Biophys 2003, 417:77-80.
35. Giulietti A., Gysemans C., Stoffels K., van Etten E., Decallonne B., Overbergh L., et al. Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice. Diabetologia 2004, 47:451-462.
36. Trembleau S., Penna G., Bosi E., Mortara A., Gately M.K., Adorini L. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 1995, 181:817-821.
37. Mathis D., Vence L., Benoist C. Beta-cell death during progression to diabetes. Nature 2001, 414:792-798.
38. Gregori S., Giarratana N., Smiroldo S., Uskokovic M., Adorini L.A. 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002, 51:1367-1374.
39. Adorini L. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Ann NY Acad Sci 2003, 987:258-261.
40. Chiu K.C., Chu A., Go V.L., Saad M.F. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004, 79:820-825.
41. Scragg R., Sowers M., Bell C. Third National Health and Nutrition Examination Survey. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004, 27:2813-2818.
42. Ford E.S., Ajani U.A., McGuire L.C., Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005, 28:1228-1230.
43. Cigolini M., Iagulli M.P., Miconi V., Galiotto M., Lombardi S., Targher G. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 2006, 29:722-724.
44. Pittas A.G., Lau J., Hu F.B., Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007, 92:2017-2029.
45. Pittas A.G., Harris S.S., Stark P.C., Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007, 30:980-986.
46. Norman A.W., Frankel J.B., Heldt A.M., Grodsky G.M. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980, 209:823-825.
47. Cade C., Norman A.W. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology 1986, 119:84-90.
48. Kadowaki S., Norman A.W. Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. J Clin Invest 1984, 73:759-766.
49. Nyomba B.L., Bouillon R., De Moor P. Influence of vitamin D status on insulin secretion and glucose tolerance in the rabbit. Endocrinology 1984, 115:191-197.
50. Zeitz U., Weber K., Soegiarto D.W., Wolf E., Balling R., Erben R.G. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 2003, 17:509-511.
51. Billaudel B.J., Faure A.G., Sutter B.C. Effect of 1,25 dihydroxyvitamin D3 on isolated islets from vitamin D3-deprived rats. Am J Physiol 1990, 258:E643-E648.
52. Danescu L.G., Levy S., Levy J. Vitamin D and diabetes mellitus. Endocrine 2009, 35:11-17.
53. Giulietti A., van Etten E., Overbergh L., Stoffels K., Bouillon R., Mathieu C. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract 2007, 77:47-57.
54. Cohen-Lahav M., Douvdevani A., Chaimovitz C., Shany S. The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages. J Steroid Biochem Mol Biol 2007, 103:558-562.
55. Saxe A.W., Gibson G., Gingerich R.L., Levy J. Parathyroid hormone decreases in vivo insulin effect on glucose utilization. Calcif Tissue Int 1995, 57:127-132.
56. Procopio M., Magro G., Cesario F., Piovesan A., Pia A., Molineri N., et al. The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed Type 2 diabetes mellitus in primary hyperparathyroidism. Diabet Med 2002, 19:958-961.
57. Teegarden D., Donkin S.S., Vitamin D. emerging new roles in insulin sensitivity. Nutr Res Rev 2009, 22:82-92.
58. Lee J.H., O'Keefe J.H., Bell D., Hensrud D.D., Holick M.F. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?. J Am Coll Cardiol 2008, 52:1949-1956.
59. Giovannucci E., Liu Y., Hollis B.W., Rimm E.B. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008, 168:1174-1180.
60. Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., Lanier K., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117:503-511.
61. Autier P., Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007, 167:1730-1737.
62. Scragg R., Jackson R., Holdaway I.M., Lim T., Beaglehole R. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol 1990, 19:559-563.
63. Poole K.E., Loveridge N., Barker P.J., Halsall D.J., Rose C., Reeve J., et al. Reduced vitamin D in acute stroke. Stroke 2006, 37:243-245.
64. Melamed M.L., Muntner P., Michos E.D., Uribarri J., Weber C., Sharma J., et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol 2008, 28:1179-1185.
65. Watson K.E., Abrolat M.L., Malone L.L., Hoeg J.M., Doherty T., Detrano R., et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997, 96:1755-1760.
66. Martins D., Wolf M., Pan D., Zadshir A., Tareen N., Thadhani R., et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007, 167:1159-1165.
67. Talmor Y., Golan E., Benchetrit S., Bernheim J., Klein O., Green J., et al. Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am J Physiol Renal Physiol 2008, 294:F1059-F1064.
68. Munger K.L., Levin L.I., Hollis B.W., Howard N.S., Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006, 296:2832-2838.
69. Craig S.M., Yu F., Curtis J.R., Alarcón G.S., Conn D.L., Jonas B., et al. Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis. J Rheumatol 2010, 37:275-281.
70. Orbach H., Zandman-Goddard G., Amital H., Barak V., Szekanecz Z., Szucs G., et al. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann NY Acad Sci 2007, 1109:385-400.
71. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006, 92:4-8.
72. Hayes C.E. Vitamin D: a natural inhibitor of multiple sclerosis. Proc Nutr Soc 2000, 59:531-535.
73. Simmons J.D., Mullighan C., Welsh K.I., Jewell D.P. Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut 2000, 47:211-214.
74. Cutolo M., Otsa K., Uprus M., Paolino S., Seriolo B. Vitamin D in rheumatoid arthritis. Autoimmun Rev 2007, 7:59-64.
75. Munger K.L., Zhang S.M., O'Reilly E., Hernán M.A., Olek M.J., Willett W.C., et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004, 13(62):60-65.
76. Meehan T.F., DeLuca H.F. The vitamin D receptor is necessary for 1alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. Arch Biochem Biophys 2002, 408:200-204.
77. Zhu Y., Mahon B.D., Froicu M., Cantorna M.T. Calcium and 1alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol 2005, 35:217-224.
78. Kamen D., Aranow C. Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol 2008, 20:532-537.
79. Wang T.T., Tavera-Mendonza L.E., Laperriere D., Libby E., MacLeod N.B., Nagai Y., et al. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxivitamin D3 target genes. Mol Endocrinol 2005, 19:2685-2695.
80. Eggert M., Klutter A., Zettl U.K., Neeck G. Transcription factors in autoimmune diseases. Curr Pharm Des 2004, 10:2787-2896.
81. Blaney G.P., Albert P.J., Proal A.D. Vitamin D metabolites as clinical markers in autoimmune and chronic disease. Ann NY Acad Sci 2009, 1173:384-390.
82. Tebtlow L.C., Wooley D.E. The effects of 1,25 dihydroxivitamin D3 on matriz metalloproteinase and prostaglandinE (2) production by cells of the reumathoid lesion. Arthritis Res 1999, 1:63-70.
83. Gysemans C., Van Etten E., Overbergh L., Giulietti A., Eelen G., Waer M., et al. Unaltered diabetes presentation in NOD mice lacking the vitamin D receptor. Diabetes 2008, 57:269-275.